Physician profile
Ayanna M Walden
NPI 1316958028
$2,048.74
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $304 · 2021: $797 · 2022: $387 · 2024: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $191.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $456.30 | 2019-2022 | |
| Therapeuticsmd, INC. | $328.32 | 2019-2022 | |
| Organon LLC | $162.79 | 2024 | |
| Agile Therapeutics, INC. | $132.47 | 2021 | |
| Evofem Biosciences, INC. | $131.69 | 2020-2021 | |
| Pfizer INC. | $114.52 | 2021-2022 | |
| Allergan, INC. | $110.46 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $97.87 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $70.52 | 2019-2020 | |
| Exeltis, USA INC. | $66.49 | 2021-2022 | |
| Lupin INC. | $60.82 | 2019-2021 | |
| Shield Therapeutics INC | $45.00 | 2022 | |
| Scynexis, INC. | $44.40 | 2022 | |
| Amag Pharmaceuticals, INC. | $43.19 | 2019 | |
| Becton, Dickinson and Company | $34.69 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $28.57 | 2024 | Aptima |
| Duchesnay USA Incorporated | $23.12 | 2019 | |
| Gilead Sciences, INC. | $18.74 | 2019 | |
| Merck Sharp & Dohme LLC | $18.57 | 2019 | |
| Avion Pharmaceuticals | $18.29 | 2022 | |
| Aspira Women'S Health INC | $15.56 | 2021 | |
| Myovant Sciences INC. | $14.36 | 2022 | |
| Daiichi Sankyo INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayanna Walden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.